Potential test systems for chemotherapeutic agents against prostatic cancer.
D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Q000378:metabolism; D000728:Androgens / Q000378:metabolism; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001119:Arginase / Q000378:metabolism; D013196:Dihydrotestosterone / Q000378:metabolism; D004195:Disease Models, Animal; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D004958:Estradiol / Q000494:pharmacology; D004961:Estramustine / Q000494:pharmacology; D004964:Estriol / Q000378:metabolism; D004967:Estrogens / Q000378:metabolism; D005485:Flutamide / Q000494:pharmacology; D000882:Haplorhini; D006801:Humans; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011467:Prostate / Q000187:drug effects / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D051381:Rats; D013739:Testosterone / Q000378:metabolism
D000728:Androgens; D000970:Antineoplastic Agents; D004967:Estrogens; D013196:Dihydrotestosterone; D004961:Estramustine; D013739:Testosterone; D004958:Estradiol; D005485:Flutamide; D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase; D001119:Arginase; D004964:Estriol